Topline results demonstrated a favorable safety profile and tolerability across four ascending dose levels in healthy volunteers and showed dose dependent levels of PMN310 antibody in Cerebrospinal fluid (CSF) suggestive of its potential for target engagement in Alzheimer’s disease...Read more
STOCKHOLM, July 26, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (STOCKHOLM: CALTX) ("Calliditas") today announced that the Phase 2b TRANSFORM trial met its primary endpoint, showing statistically significant improvement in ALP (Alkaline Phosphatase) for both doses...Read more
THRIVE-2 exceeded its enrollment target due to patient demand; 188 patients enrolled with approximately 40% from US sites THRIVE topline readout in patients with active TED on track for September 2024 THRIVE-2 topline readout on track for year-end 2024 WALTHAM,...Read more
FOSTER CITY, Calif. / Jul 25, 2024 / Business Wire / Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for LIVMARLI® (maralixibat) oral solution for the treatment of cholestatic pruritus in patients with...Read more
Sickle cell disease affects approximately 100,000 patients in the U.S. annually and is a debilitating and life-threatening condition with high unmet need Current conditioning with non-targeted chemotherapies provides limited access to potentially curative bone marrow transplant and...Read more
ALL represents 10% of all leukemia cases in the United States, progresses rapidly, and is typically fatal within weeks or months if left untreated1 There is an urgent need to develop new therapies for ALL for patients who are not candidates for hematopoietic stem cell transplantation (HSCT) or...Read more
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE| Company | Change | Last Trade |
|---|---|---|
| Mettler-Toledo | 39.08 2.77 | $1,450.08 |
| Regeneron Pharmaceuticals | 14.44 1.36 | $1,078.63 |
| Elevance Health | 13.47 2.62 | $527.50 |
| Thermo Fisher Scientific | 12.64 2.13 | $607.14 |
| Charles River Laboratories | 11.66 5.26 | $233.47 |
| Molina Healthcare | 11.19 3.45 | $335.36 |
| ICON | 10.36 3.31 | $323.46 |
| UnitedHealth | 10.04 1.79 | $569.72 |
| Univerl Health Services | 8.70 4.24 | $213.69 |
| Repligen | 8.43 6.37 | $140.79 |
| Chemed | 8.30 1.53 | $549.27 |
| argenx | 8.13 1.67 | $494.46 |
| Waters | 7.67 2.47 | $317.96 |
| West Pharmaceutical | 7.60 2.74 | $284.76 |
| IQVIA | 7.38 3.18 | $239.67 |
| ZIVO Bioscience | 7.25 659.09 | $8.35 |
| Ensign | 6.63 4.87 | $142.80 |
| Humana | 6.23 1.61 | $392.63 |
| Company | Volume | Last Trade |
|---|---|---|
| Sangamo Therapeutics | 123,118,826 | $0.86 |
| CEL-SCI | 58,189,490 | $1.31 |
| Tivic Health Systems | 57,686,652 | $0.45 |
| DexCom | 53,667,927 | $64.00 |
| Windtree Therapeutics | 48,202,905 | $8.29 |
| Ginkgo Bioworks | 42,957,152 | $0.37 |
| Vyome | 36,361,564 | $0.22 |
| Pfizer | 33,615,246 | $30.77 |
| Bristol-Myers Squibb | 31,408,167 | $50.45 |
| CareMax | 22,900,488 | $6.39 |
| Walgreens Boots Alliance | 14,454,291 | $11.82 |
| Allarity Therapeutics | 14,022,505 | $0.22 |
| PacBio | 13,833,185 | $2.14 |
| Edwards Lifesciences | 13,085,009 | $62.37 |
| Geron | 12,613,532 | $4.66 |
| CVS Health | 10,176,010 | $61.00 |
| Viking Therapeutics | 9,115,922 | $65.98 |
| Centene | 8,646,414 | $73.10 |
| Teva Pharmaceutical | 8,418,361 | $17.10 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
